Cartalax Usage And Synthesis

Description

Cartalax is also known as Ala-Glu-Asp. Cartalax is a short-chain peptide with tissue-specific activity on the cartilage tissue with direct DNA interaction. It is a first-class geroprotective and regenerative medicine.

Clinical Use

Clinical studies have proven the efficiency of Cartalax in comprehensive prevention and treatment of patients with spinal osteochondrosis, osteoarthritis, osteoporosis, after injuries and fractures, as well as in the prevention of sclerotic and degenerative processes in the spine and joints in elderly patients